Trinity Biotech: Rises on Q3 revenue beat

Trinity Biotech

17/11/2020 15:52

** U.S.-listed shares of diagnostic products maker  TRIB.O 
up 2.9% at $3.16 
    ** Co posts Q3 rev of $32 mln, above analysts' estimates of
$28 mln, according to Refinitiv IBES data  urn:newsml:reuters.com:*:nGNX3LHrp5
    ** TRIB says it saw strong sales of COVID-19-related
products and higher demand for co's rapid respiratory products 
    ** Co says its selling, general and administrative expenses
fell 13.7% to $6.3 mln 
    ** Net profit was 32 cents per share
    ** Co names John Gillard as chief financial officer 
    ** TRIB shares are up 205.9% so far this year

 (Reporting by Lasya Priya M in Bengaluru)
 ((LasyaPriya.M@thomsonreuters.com;))